OR WAIT 15 SECS
Associate Editor for Contemporary OB/GYN
According to new research, women with ductal carcinoma in situ (DCIS) are more than three times as likely to suffer from breast cancer mortality than women in the general population.
Researchers from the University of Toronto conducted a study, published in JAMA Network Open, that investigated the actual risk of death associated with DCIS in women with a DCIS diagnosis between 1995 and 2014.
“In the population studied, the risk of dying of breast cancer…suggests that our current treatment focus on preventing invasive recurrence is insufficient to eliminate all deaths from breast cancer after DCIS,” said the team led by Vasily Giannakeas, MPH, a doctoral candidate at the University of Toronto and Women’s College Research Institute.